Loews Corp’s GSK GSK Stock Holding History

Loews Corp’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-248,000	Closed	-$15.5M	–	194
2013 Q2	$15.5M	Buy	+248,000	New	+$15.7M	0.09%	23

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

Loews Corp's GSK Position: Q3 2013 in Review

Loews Corp sold out of GSK (GSK) in Q3 2013, closing a stake of 248,000 shares — an estimated $15.5M sold.

Loews Corp first reported a position in GSK in Q2 2013 and held it in 1 quarter. The position peaked at $15.5M in Q2 2013. 635 funds tracked by Wall St. Rank hold GSK as of Q3 2013.

Loews Corp reported no remaining GSK position as of Q3 2013 after selling out during the quarter.
Loews Corp sold 248,000 GSK shares in Q3 2013, an estimated $15.5M.
Loews Corp first reported a position in GSK in Q2 2013 and held it in 1 quarter.
Loews Corp's GSK position peaked at $15.5M in Q2 2013.
635 funds tracked by Wall St. Rank held GSK as of Q3 2013.

Based on Loews Corp's 13F filing for Q3 2013, filed 13 Nov 2013.